Sort
40,608 grants matching “prostate cancer”
Targeted Nano-drug-delivery-systems of Frist-in-class Drugs for CRPC: PK/PD Evaluation and Combination Therapy
$342,330Huan Xie · Texas Southern University · U54 · FY2024 · MD
Computational and Experimental Modeling of Alternative Polyadenylation
$342,290Wei Li · University Of California-Irvine · R01 · FY2024 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER INTOBAGONIANS
$342,283University Of Pittsburgh At Pittsburgh · R01 · FY2003 · CA
Costimulation Enhances Murine T Cells in Cancer Vaccine Development
$342,267Helen Sabzevari · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Cytokines to control the immune response in cancer vaccine development
$342,267Helen Sabzevari · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
AN UNKNOWN ROLE OF ARGINYLATION IN PROSTATE CANCER
$342,254University Of Miami · · FY2015 · Department of the Army
OHSU Center for Specialized Data Analysis as part of the GDAN
$342,253Kyle Ellrott · Oregon Health & Science University · U24 · FY2024 · CA
Proteomics Approaches to Benign Prostatic Hyperplasia.
$342,245Brigham And Women'S Hospital · U01 · FY2003 · DK
Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer
$342,229James F. Rusling · University Of Connecticut Storrs · R01 · FY2016 · EB
Modulating the Inflammasome to Generate Robust Cell Mediated Immunity
$342,228John-Demian Sauer · University Of Wisconsin-Madison · R01 · FY2016 · CA
Modulating the Inflammasome to Generate Robust Cell Mediated Immunity
$342,228John-Demian Sauer · University Of Wisconsin-Madison · R01 · FY2017 · CA
Modulating the Inflammasome to Generate Robust Cell Mediated Immunity
$342,228John-Demian Sauer · University Of Wisconsin-Madison · R01 · FY2015 · CA
Environmentally-adaptive nanoparticles with focal irradiation for cancer therapy
$342,216Yoon Yeo · Purdue University · R01 · FY2015 · EB
Molecular Imaging of Retrograde Nerve Transport
$342,170Dawid None Schellingerhout · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · NS
Virtual Conversations for Prostate Cancer Decisions
$342,158William Glenn Harless · Interactive Drama, Inc. · R44 · FY2010 · CA
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer
$342,141Koon Y Pak · Molecular Targeting Technologies, Inc. · R44 · FY2009 · CA
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
$342,100Richard J Auchus · University Of Michigan At Ann Arbor · R01 · FY2014 · GM
MANAGING UNCERTAINTY IN ADVANCED PROSTATE CANCER
$342,099University Of North Carolina Chapel Hill · R01 · FY2001 · NR
MULTIVALENT PEPTIDOMIMETIC CONJUGATES AS INHIBITORS OF ANDROGEN RECEPTOR FUNCTION IN THERAPY-RESISTANT PROSTATE CANCER
$342,087Scripps Research Institute, The · · FY2015 · Department of Defense
Phosphorylation-dependent regulation of GLI transcription factors
$342,071Scott Atwood · University Of California-Irvine · R01 · FY2022 · CA
Mullerian Inhibiting Substance
$342,070Massachusetts General Hospital · R01 · FY2005 · CA
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
$342,013Hamid Ghandehari · University Of Utah · R01 · FY2020 · CA
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
$342,013Hamid Ghandehari · University Of Utah · R01 · FY2021 · CA
MYOSIN VI FUNCTION AND MECHANISM
$342,000Kathryn G Miller · Washington University · R01 · FY2009 · GM
MYOSIN VI FUNCTION AND MECHANISM
$342,000Kathryn G Miller · Washington University · R01 · FY2008 · GM